Skip to main content
PROTEINA CO.,LTD. logo

PROTEINA CO.,LTD. — Investor Relations & Filings

Ticker · 468530 ISIN · KR7468530001 KO Professional, scientific and technical activities
Open in API
Filings indexed 58 across all filing types
Latest filing 2025-07-23 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 468530

About PROTEINA CO.,LTD.

https://www.proteina.co.kr/en/

PROTEINA CO., LTD. is a biotechnology company specializing in proteomics, with a core focus on analyzing protein-protein interactions (PPIs). The company's proprietary SPID (Single-molecule Protein Interaction Detection) platform provides real-time, high-resolution insights into protein complexes with exceptional sensitivity. This technology is applied to discover novel drug candidates, develop PPI biomarkers, and advance new approaches to disease diagnostics. PROTEINA aims to drive the development of next-generation precision therapies by revolutionizing the understanding of protein interactions.

Recent filings

Filing Released Lang Actions
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a public offering, including subscription and allocation data, shareholding changes, and the use of proceeds. This document is a formal regulatory filing confirming the completion of a capital-raising event (IPO/share issuance) and does not fit into categories like 'Earnings Release' or 'Annual Report'. It is a specific regulatory disclosure regarding share issuance and capital changes.
2025-07-23 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for Proteina Co., Ltd. and includes specific details on share allocation, underwriting, and offering procedures. This type of regulatory filing for a public offering is classified as a Regulatory Filing (RNS) as it is a formal submission to a regulatory body regarding the terms of a securities issuance.
2025-07-16 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '정정신고서' (Amendment Filing) for an '투자설명서' (Investment Prospectus) regarding a public offering of shares by '주식회사 프로티나' (Protina Co., Ltd.). It details changes to the offering price, total offering amount, and allocation ratios following the determination of the final offering price. This is a formal regulatory filing related to a securities offering, which falls under the category of Regulatory Filings (RNS) as it is a specific type of legal/regulatory disclosure document that does not fit into the other specialized categories like 10-K, ER, or IP.
2025-07-16 Korean
투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '투자설명서' (Investment Prospectus) for '주식회사 프로티나' (Protina Co., Ltd.) dated July 14, 2025. It details a public offering of 1,500,000 shares, subscription periods, and investment risk factors. In the context of Korean financial filings (DART system), a '투자설명서' is a formal document filed for public offerings, which falls under the category of a Prospectus or Offering Statement. Given the provided schema, 'PSI' (Proxy Solicitation & Information Statement) is the closest fit for offering materials and information statements provided to potential investors/shareholders, although it is technically a Prospectus. However, since it is a formal regulatory filing for a public offering, it is classified as a Proxy Solicitation & Information Statement (PSI) as it serves to inform and solicit investment.
2025-07-14 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Protina. This is a regulatory filing required by the Financial Supervisory Service (FSS) in South Korea for companies preparing for an IPO or capital raise. It details specific amendments to the original registration statement, including updates to risk factors, financial projections, and business performance data. As it is a formal regulatory filing for securities registration, it falls under the 'Regulatory Filings' category.
2025-07-11 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed by Proteina. It explicitly mentions multiple amendments (1st through 5th) and provides detailed information regarding the offering, business outlook, and financial projections for the purpose of a public offering. This type of regulatory filing for securities registration is classified under 'Regulatory Filings' (RNS) as it is a formal submission to the financial regulatory authority (FSS/DART) that does not fit into the specific categories like 10-K or Earnings Release.
2025-07-11 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.